Clinical Trial

A Clinical Study of HRS-5765 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this phase I study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of HRS-5765 in healthy participants.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-27
Trial Details
NCT Number NCT07551167
Lead Sponsor Chengdu Suncadia Medicine Co., Ltd.
Conditions Heart Failure
Enrollment 74 participants
Start Date 2026-05-20
Primary Completion 2026-12 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-26